Immunotherapy of Rheumatoid Arthritis Targeting Inflammatory Cytokines and Autoreactive T Cells

被引：25
作者：
Chen, Guangjie [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Immunol, Shanghai 200025, Peoples R China
来源：
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS | 2010年 / 58卷 / 01期
关键词：
Rheumatoid arthritis; Immunotherapy; Inflammatory cytokines; Autoreactive T cells; Regulatory T cells; Th17; cells; PLACEBO-CONTROLLED TRIAL; NECROSIS-FACTOR-ALPHA; COLLAGEN-INDUCED ARTHRITIS; ANTI-INTERLEUKIN-6 RECEPTOR ANTIBODY; CONTROLLED CLINICAL-TRIAL; LONG-TERM SAFETY; PHASE-III TRIAL; DOUBLE-BLIND; TNF-ALPHA; RANDOMIZED-TRIAL;
D O I：
10.1007/s00005-009-0058-1
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Rheumatoid arthritis is a chronic disorder for which there is no known cure. Concentrating on specific elements of the abnormal immune response that characterizes the disease, scientists are reaching into biotechnology's bag of tricks to develop immunotherapeutic techniques. This paper will present some advances in the immunotherapy of rheumatoid arthritis targeting inflammatory cytokines and autoreactive T cells.
引用
收藏
页码：27 / 36
页数：10
相关论文
共 100 条
[1]   Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells [J].
Acosta-Rodriguez, Eva V. ;
Rivino, Laura ;
Geginat, Jens ;
Jarrossay, David ;
Gattorno, Marco ;
Lanzavecchia, Antonio ;
Sallusto, Federica ;
Napolitani, Giorgio .
NATURE IMMUNOLOGY, 2007, 8 (06) :639-646
[2]   The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease [J].
Afzali, B. ;
Lombardi, G. ;
Lechler, R. I. ;
Lord, G. M. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2007, 148 (01) :32-46
[3]   Characterization of the bone-resorptive effect of interleukin-11 in cultured mouse calvarial bones [J].
Ahlen, J ;
Andersson, S ;
Mukohyama, H ;
Roth, C ;
Bäckman, A ;
Conaway, HH ;
Lerner, UH .
BONE, 2002, 31 (01) :242-251
[4]   Interleukin 6 is required for the development of collagen-induced arthritis [J].
Alonzi, T ;
Fattori, E ;
Lazzaro, D ;
Costa, P ;
Probert, L ;
Kollias, G ;
De Benedetti, F ;
Poli, V ;
Ciliberto, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (04) :461-468
[5]   Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis [J].
Andersson, A. K. ;
Feldmann, M. ;
Brennan, F. M. .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2008, 68 (01) :103-111
[6]   ACTIVATION OF T-CELLS RECOGNIZING SELF 60-KD HEAT-SHOCK PROTEIN CAN PROTECT AGAINST EXPERIMENTAL ARTHRITIS [J].
ANDERTON, SM ;
VANDERZEE, R ;
PRAKKEN, B ;
NOORDZIJ, A ;
VANEDEN, W .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03) :943-952
[7]  
Ausar SF, 2001, RHEUMATOL INT, V20, P138
[8]   Adalimumab - A review of its use in rheumatoid arthritis [J].
Bang, LM ;
Keating, GM .
BIODRUGS, 2004, 18 (02) :121-139
[9]   A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis [J].
Barnett, ML ;
Combitchi, D ;
Trentham, DE .
ARTHRITIS AND RHEUMATISM, 1996, 39 (04) :623-628
[10]  
Barnett ML, 1998, ARTHRITIS RHEUM, V41, P290, DOI 10.1002/1529-0131(199802)41:2<290::AID-ART13>3.3.CO
12345678910